Sprint Precision Technologies
688605
Jiangsu Jingxue Insulation Technology
301010
Global Infotech
300465
Hydsoft Technology
301316
SGSG Science&Technology
300561
CN Stock MarketDetailed Quotes
002864 Shaanxi Panlong Pharmaceutical
- 31.56
- +2.87+10.00%
Market Closed Dec 12 15:00 CST
3.35BMarket Cap28.93P/E (TTM)
31.56High28.59Low87.98KlotVolume28.68Open28.69Pre Close272.31MTurnover11.89%Turnover Ratio30.38P/E (Static)106.28MShares40.5852wk High2.09P/B2.33BFloat Cap21.7852wk Low31.56Limit Up73.98MShs Float80.26Historical High25.82Limit Down10.35%Amplitude10.94Historical Low0.22Dividend TTM30.95Avg Price60.80KlotAsk0.70%Div YieldTTM100Lot Size23.70KlotBid
Shaanxi Panlong Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 3.21%778.83M | -0.15%510.55M | 9.72%256.33M | 5.03%1.02B | 6.38%754.61M | 5.63%511.31M | -1.43%233.62M | 5.80%975.71M | 8.38%709.37M | 18.93%484.05M |
| Cash received relating to other operating activities | 14.10%38.37M | 22.99%27.61M | 9.78%15.61M | -24.11%54.82M | -37.45%33.63M | 22.27%22.45M | 31.38%14.22M | 59.25%72.24M | 145.63%53.77M | 7.09%18.36M |
| Cash inflows from operating activities | 3.67%817.2M | 0.82%538.16M | 9.73%271.95M | 3.02%1.08B | 3.29%788.24M | 6.24%533.76M | 0.00%247.84M | 8.30%1.05B | 12.82%763.14M | 18.45%502.41M |
| Goods services cash paid | -3.82%269.64M | -22.86%162.42M | -42.15%68.84M | -3.37%406.07M | -6.13%280.36M | 4.87%210.55M | 37.66%118.99M | 9.63%420.25M | 24.17%298.67M | 22.99%200.77M |
| Staff behalf paid | -1.95%57.36M | -6.14%38.28M | -21.82%16.98M | 4.08%79.29M | 3.57%58.5M | 8.02%40.79M | 11.47%21.71M | 14.39%76.17M | 15.90%56.48M | 16.85%37.76M |
| All taxes paid | 1.46%75.56M | 9.40%54.59M | 69.14%30.13M | 2.61%95.65M | 6.46%74.47M | 0.34%49.9M | -4.86%17.81M | 10.01%93.22M | 5.30%69.95M | 8.66%49.73M |
| Cash paid relating to other operating activities | -2.17%286.3M | -0.65%171.71M | 5.39%92.52M | 18.51%394.56M | 31.11%292.65M | 21.99%172.84M | 4.80%87.79M | 5.06%332.94M | -6.47%223.21M | -2.43%141.69M |
| Cash outflows from operating activities | -2.43%688.85M | -9.93%427M | -15.37%208.47M | 5.74%975.57M | 8.90%705.98M | 10.26%474.07M | 18.19%246.32M | 8.34%922.58M | 9.08%648.31M | 11.23%429.94M |
| Net cash flows from operating activities | 56.03%128.35M | 86.23%111.16M | 4,068.91%63.48M | -17.00%104.05M | -28.37%82.26M | -17.63%59.69M | -96.14%1.52M | 8.04%125.36M | 39.92%114.83M | 92.76%72.46M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | --5M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received from returns on investments | -47.21%2M | --2M | --2M | --5.58M | --3.79M | ---- | ---- | ---- | ---- | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -85.15%19.78K | -85.32%19.49K | ---- | 404.63%152.73K | --133.21K | --132.74K | --132.74K | 5.66%30.27K | ---- | ---- |
| Cash received relating to other investing activities | ---- | ---- | ---- | -94.24%1.63M | --6M | --6M | ---- | --28.24M | ---- | ---- |
| Cash inflows from investing activities | -79.64%2.02M | -67.07%2.02M | 1,406.67%2M | -56.28%12.36M | --9.92M | --6.13M | --132.74K | 98,582.44%28.27M | ---- | ---- |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 23.69%57.87M | 52.65%41.56M | 41.69%25.69M | 11.96%62.51M | -11.89%46.79M | -26.11%27.23M | -7.47%18.13M | -30.79%55.84M | -14.45%53.1M | -5.91%36.85M |
| Cash paid to acquire investments | ---- | ---- | ---- | -73.90%2.61M | ---- | ---- | ---- | --10M | --10M | --10M |
| Net cash paid to acquire subsidiaries and other business units | --23.49M | --23.49M | --23.49M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | --9.64M | --9.64M | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | 44.18%81.36M | 138.92%65.05M | 171.24%49.18M | 13.57%74.77M | -10.57%56.43M | -41.88%27.23M | -7.47%18.13M | -23.25%65.84M | 1.67%63.1M | 19.62%46.85M |
| Net cash flows from investing activities | -70.59%-79.34M | -198.80%-63.03M | -162.13%-47.18M | -66.12%-62.41M | 26.29%-46.51M | 54.97%-21.1M | 8.14%-18M | 56.19%-37.57M | -1.71%-63.1M | -19.62%-46.85M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | 1,863.13%298.75M | 1,847.25%296.34M | 1,430.61%1.5M | ---- | 1,421.82%15.22M | 1,421.82%15.22M | -90.20%98K |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | 920.41%1.5M | 920.41%1.5M | 1,430.61%1.5M | ---- | -85.30%147K | --147K | -90.20%98K |
| Cash from borrowing | 15.78%150M | 42.86%150M | 50.00%150M | -14.58%134.1M | -17.48%129.55M | -33.12%105M | -28.57%100M | 214.00%157M | 214.00%157M | 214.00%157M |
| Cash received relating to other financing activities | ---- | ---- | ---- | -99.98%63K | -98.95%2.86M | -99.87%364.95K | -99.92%213.64K | 36,933.42%274.69M | 17,847.13%273.29M | 25,916.78%276.76M |
| Cash inflows from financing activities | -65.01%150M | 40.36%150M | 49.68%150M | -3.13%432.92M | -3.76%428.74M | -75.37%106.86M | -75.82%100.21M | 763.73%446.91M | 748.22%445.51M | 733.33%433.86M |
| Borrowing repayment | -38.09%100.5M | -22.16%100M | -6.10%100M | 62.02%166.88M | 57.60%162.32M | 33.13%128.47M | 129.03%106.5M | 930.59%103M | 930.59%103M | 865.56%96.5M |
| Dividend interest payment | 7.16%25.75M | 8.97%24.84M | -72.83%779.86K | 15.24%24.3M | 25.90%24.03M | 21.16%22.8M | 117.23%2.87M | 17.86%21.09M | 7.11%19.08M | 17.32%18.82M |
| Cash payments relating to other financing activities | 115.31%10.58M | 216.26%10.58M | ---- | -25.71%4.81M | -13.13%4.91M | -17.28%3.35M | 117.48%1.55M | -61.53%6.48M | -51.15%5.66M | -62.25%4.05M |
| Cash outflows from financing activities | -28.46%136.83M | -12.41%135.43M | -9.14%100.78M | 50.11%195.99M | 49.73%191.26M | 29.54%154.62M | 128.54%110.92M | 191.91%130.56M | 224.29%127.74M | 224.81%119.36M |
| Net cash flows from financing activities | -94.45%13.17M | 130.52%14.57M | 559.74%49.22M | -25.10%236.93M | -25.27%237.48M | -115.18%-47.75M | -102.93%-10.71M | 4,409.89%316.35M | 2,319.75%317.77M | 1,953.55%314.5M |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | -77.24%62.18M | 784.37%62.7M | 341.06%65.52M | -31.07%278.57M | -26.05%273.23M | -102.69%-9.16M | -107.05%-27.18M | 983.42%404.14M | 1,014.17%369.5M | 2,374.55%340.11M |
| Add:Begin period cash and cash equivalents | 33.83%1.1B | 33.83%1.1B | 33.83%1.1B | 96.38%823.44M | 96.38%823.44M | 96.38%823.44M | 96.38%823.44M | 9.76%419.3M | 9.76%419.3M | 9.76%419.3M |
| End period cash equivalent | 6.16%1.16B | 43.04%1.16B | 46.63%1.17B | 33.83%1.1B | 39.03%1.1B | 7.22%814.28M | -1.09%796.26M | 96.38%823.44M | 90.00%788.81M | 91.90%759.42M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
